Faricimab
Indication
Diabetic macular oedema - NICE TA799
Red
Brand:
Nice TA:
799
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Eye
Background
1.1 Faricimab is recommended as an option for treating visual impairment due to diabetic macular oedema in adults, only if:
-
the eye has a central retinal thickness of 400 micrometres or more at the start of treatment
-
the company provides faricimab according to the commercial arrangement.